Efficacy and safety of Oral pirocarpin for xerostomia patients.

Efficacy and safety of Oral pirocarpin for xerostomia patients. - Study on xerostomia patients.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000005276

Enrollment

Registered

2011-04-01

Start date

2011-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

xerostomia

Interventions

5mg of oral pilocarpine three times daily 24 weeks follow up

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: xerostomia patients

Exclusion criteria

Exclusion criteria: Contraindication to oral pilocarpine. Pregnancy or women with suspected pregnancy. The patients who could not be provided with informed consent. Unsuitability for the trial based on clinical judgement.

Design outcomes

Primary

Measure	Time frame
Quantity of the stimulated saliva Level of oral moisture measured by a moisture checker	—

Countries

Japan

Contacts

Public ContactYumiko Ohbayashi

Kagawa University Department of Oral and Maxillofacial Surgery

087-891-2227

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026